NCT04706559View on ClinicalTrials.gov

Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

January 3, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

December 15, 2021

Conditions
Atopic Dermatitis
Interventions
DRUG

Probiotic sachet containing mixture of four strains i.e.Lactobacillus rhamnosus, Lactobacillus acidophilus, Bifidobacterium longum, and Saccharomyces boulardii

Interventional group: Children with AD meeting eligibility criteria receiving probiotics and conventional treatment (topical corticosteroid, topical tacrolimus, an oral antihistamine and emollients).

DRUG

Conventional treatment

topical corticosteroid, topical tacrolimus, an oral antihistamine and emollients as per atopic dermatitis treatment guidelines.

Trial Locations (1)

7053

B.P. Koirala Institute of Health Sciences, Dharān

All Listed Sponsors
collaborator

Nepal Health Research Council

OTHER_GOV

lead

B.P. Koirala Institute of Health Sciences

OTHER

NCT04706559 - Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis | Biotech Hunter | Biotech Hunter